HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

HENLIUS

71.300

-2.200-2.99%

Volume:565.84K

Turnover:40.77M

Market Cap:38.75B

PE:43.35

High:73.500

Open:73.500

Low:71.000

Close:73.500

52wk High:92.000

52wk Low:15.200

Shares:543.49M

HK Float Shares:163.43M

Volume Ratio:0.87

T/O Rate:0.35%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.645

ROE:27.54%

ROA:4.97%

PB:10.44

PE(LYR):43.35

PS:6.13

Loading ...

Overview Company News Filings

BRIEF-Shanghai Henlius Biotech Says NMPA Approves Phase 1B/2 Trial For Hlx43 And Hlx07

HENLIUS (02696): NMPA Approves Phase 1b/2 Clinical Trial Application for HLX43 Injection Combined with HLX07 in Advanced/Metastatic Solid Tumors

Shanghai Henlius Biotech Receives Regulatory Approval to Begin Phase 1b/2 Clinical Trial of HLX43 Combination Therapy for Advanced Solid Tumours in China

Shanghai Henlius Biotech Inc - Nmpa Approves Phase 1B/2 Trial for Hlx43 and Hlx07

THOMSON REUTERS

HENLIUS (02696): FDA Approves Phase 1 Clinical Trial Application for HLX13 as First-Line Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients

Shanghai Henlius Biotech Receives FDA Approval for IND Application of HLX13 Ipilimumab Biosimilar for First-Line Treatment of Unresectable Hepatocellular Carcinoma

Shanghai Henlius Biotech Inc - FDA Approves Ind for Hlx13 for Unresectable Hcc

THOMSON REUTERS

HENLIUS (02696) Completes First Patient Dosing in China for International Multi-Center Phase 1 Clinical Trial of Independently Developed Pembrolizumab Biosimilar HLX17 in Patients with Various Resected Solid Tumors

Shanghai Henlius Biotech Doses First Patient in International Phase 1 Trial of Pembrolizumab Biosimilar HLX17 for Solid Tumours

What Recent Partnership News Means for Shanghai Henlius Biotech’s Valuation in 2025

Simply Wall St.

Is Shanghai Henlius Biotech (SEHK:2696) Fairly Valued? A Fresh Look at Current Market Expectations

Simply Wall St.

European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

Organon, Shanghai Henlius Say EU Approves Denosumab Biosimilars

MT Newswires Live

HENLIUS (02696): European Commission Approves HLX14 (Denosumab) Products for Osteoporosis Treatment in Specific Patient Populations

European Commission (Ec) Approves Henlius and Organon’s Bildyos® (Denosumab) and Bilprevda® (Denosumab), Biosimilars to Prolia (Denosumab) and Xgeva (Denosumab), Respectively

THOMSON REUTERS

Shanghai Henlius Biotech Inc - Bilprevda® Approved for Skeletal Event Prevention

THOMSON REUTERS

Shanghai Henlius Biotech Inc - Ec Approves Hlx14 Products for Osteoporosis Treatment

THOMSON REUTERS

Henlius Biotech Doses First Patient in Lung Cancer Drug Trial in Australia

MT Newswires Live

HENLIUS (02696): First Patient Dosed in Australia for International Multi-center Phase 2 Clinical Study of HLX43 (PD-L1 Targeted Antibody-Drug Conjugate) for Advanced Non-Small Cell Lung Cancer Treatment

China Merchants Securities Maintains "Strong Recommendation" Rating on HENLIUS (02696), Optimistic About HLX43's Drug Development Potential

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02696/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"HENLIUS","latestPrice":71.3,"timestamp":1759738117008,"preClose":73.5,"halted":0,"volume":565842,"delay":0,"floatShares":163428541,"shares":543494853,"eps":1.644783821985617,"marketStatus":"Closed The day following the Chinese Mid-Autumn Festival","change":-2.2,"latestTime":"10-06 16:08:37","open":73.5,"high":73.5,"low":71,"amount":40773694,"amplitude":0.034014,"askPrice":71.4,"askSize":15200,"bidPrice":71.3,"bidSize":1600,"shortable":3,"etf":0,"ttmEps":1.6524541585255754,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1759887000000},"marketStatusCode":7,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":73.5,"openAndCloseTimeList":[[1759714200000,1759723200000],[1759726800000,1759737600000]],"volumeRatio":0.8744247427145828,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","floatShares":163428541,"roa":"4.97%","roe":"27.54%","lyrEps":1.64464,"volumeRatio":0.8744247427145828,"shares":543494853,"dividePrice":0,"high":73.5,"amplitude":0.034014,"preClose":73.5,"low":71,"week52Low":15.2,"pbRate":"10.44","psRate":"6.13","week52High":92,"institutionHeld":0,"latestPrice":71.3,"committee":-0.809524,"eps":1.644639675780429,"divideRate":0,"volume":565842,"delay":0,"ttmEps":1.6523093401044464,"open":73.5,"prevYearClose":23.7,"prevWeekClose":73.5,"prevMonthClose":75.3,"prevQuarterClose":75.3,"fiveDayClose":71.55,"twentyDayClose":81.85,"sixtyDayClose":52.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02696\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null},{"date":"2025-03-24","symbol":"02696","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"market":"HK","date":"2025-02-10","symbol":"02696","reason":null,"defaultRemindTime":1739151000000,"announcedDate":"2024-12-23","type":"delisting","dateTimestamp":1739116800000},{"market":"HK","date":"2024-08-26","symbol":"02696","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-21","symbol":"02696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710984600000,"name":null,"time":"","dateTimestamp":1710950400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1756483200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02696","date":"2025-10-03","current":43.149541,"percent":0.896104,"low":-39.586964,"twenty":-15.928376,"median":-7.944262,"eighty":20.881711,"high":139.007258,"avg":7.620811,"sd":36.862112,"marketCap":39946871695},"quantilePoints":[{"date":"2020-10-09","current":-22.131906,"twenty":-34.486728,"median":-29.695291,"eighty":-25.001255,"marketCap":25788830774},{"date":"2020-10-16","current":-21.044441,"twenty":-34.418467,"median":-29.528739,"eighty":-24.598816,"marketCap":24511617870},{"date":"2020-10-23","current":-19.078404,"twenty":-34.27602,"median":-29.444151,"eighty":-23.735509,"marketCap":22256114230},{"date":"2020-10-30","current":-17.328623,"twenty":-34.194709,"median":-29.363571,"eighty":-23.574442,"marketCap":20218008531},{"date":"2020-11-06","current":-16.345604,"twenty":-34.136242,"median":-29.283556,"eighty":-23.32002,"marketCap":19294067281},{"date":"2020-11-13","current":-15.411779,"twenty":-34.115783,"median":-29.265473,"eighty":-22.72894,"marketCap":18207077575},{"date":"2020-11-20","current":-17.030179,"twenty":-34.006451,"median":-29.093442,"eighty":-22.396986,"marketCap":20245183274},{"date":"2020-11-27","current":-20.575741,"twenty":-33.890414,"median":-28.852641,"eighty":-22.218565,"marketCap":24402918899},{"date":"2020-12-04","current":-19.382288,"twenty":-33.810417,"median":-28.644543,"eighty":-22.050341,"marketCap":23152880737},{"date":"2020-12-11","current":-18.813075,"twenty":-33.661797,"median":-28.517861,"eighty":-21.565285,"marketCap":22419162686},{"date":"2020-12-18","current":-19.579463,"twenty":-33.232461,"median":-28.420437,"eighty":-20.87362,"marketCap":23370278679},{"date":"2020-12-24","current":-19.900439,"twenty":-32.90058,"median":-28.320519,"eighty":-20.447832,"marketCap":23777899818},{"date":"2020-12-31","current":-21.347266,"twenty":-32.738825,"median":-28.072361,"eighty":-20.405196,"marketCap":25517083348},{"date":"2021-01-08","current":-20.007648,"twenty":-21.027696,"median":-20.057143,"eighty":-19.872325,"marketCap":24131171473},{"date":"2021-01-15","current":-18.953047,"twenty":-20.538983,"median":-19.867005,"eighty":-19.394728,"marketCap":22826783826},{"date":"2021-01-22","current":-19.863933,"twenty":-20.368146,"median":-19.863933,"eighty":-19.394728,"marketCap":23913773532},{"date":"2021-01-29","current":-17.730953,"twenty":-20.273574,"median":-19.738569,"eighty":-18.960572,"marketCap":21522396178},{"date":"2021-02-05","current":-17.567528,"twenty":-20.124621,"median":-19.454728,"eighty":-18.3532,"marketCap":21196299267},{"date":"2021-02-11","current":-18.846812,"twenty":-20.037345,"median":-19.387263,"eighty":-18.043904,"marketCap":22772434340},{"date":"2021-02-19","current":-17.894416,"twenty":-19.98484,"median":-18.965589,"eighty":-17.952934,"marketCap":21631095149},{"date":"2021-02-26","current":-17.122755,"twenty":-19.887674,"median":-18.91395,"eighty":-17.817431,"marketCap":20652804414},{"date":"2021-03-05","current":-17.481999,"twenty":-19.859226,"median":-18.774495,"eighty":-17.800508,"marketCap":21033250811},{"date":"2021-03-12","current":-17.195892,"twenty":-19.837295,"median":-18.44057,"eighty":-17.499595,"marketCap":20652804414},{"date":"2021-03-19","current":-16.86211,"twenty":-19.790352,"median":-18.12726,"eighty":-17.253113,"marketCap":20245183274},{"date":"2021-03-26","current":-17.181113,"twenty":-19.623559,"median":-18.062887,"eighty":-17.138564,"marketCap":20272358016},{"date":"2021-04-01","current":-19.512345,"twenty":-19.512345,"median":-18.076073,"eighty":-17.177529,"marketCap":22962657539},{"date":"2021-04-09","current":-18.271256,"twenty":-19.510182,"median":-18.12726,"eighty":-17.179679,"marketCap":21549570921},{"date":"2021-04-16","current":-18.363013,"twenty":-19.476333,"median":-18.248673,"eighty":-17.18998,"marketCap":21739794120},{"date":"2021-04-23","current":-19.645162,"twenty":-19.476333,"median":-18.226089,"eighty":-17.316751,"marketCap":23315929193},{"date":"2021-04-30","current":-19.040057,"twenty":-19.648003,"median":-18.297927,"eighty":-17.448129,"marketCap":22690910112},{"date":"2021-05-07","current":-17.965945,"twenty":-19.565472,"median":-18.363013,"eighty":-17.482435,"marketCap":21549570921},{"date":"2021-05-14","current":-18.113671,"twenty":-19.510182,"median":-18.274791,"eighty":-17.482435,"marketCap":21712619377},{"date":"2021-05-21","current":-18.357986,"twenty":-19.487135,"median":-18.274791,"eighty":-17.516465,"marketCap":22011541546},{"date":"2021-05-28","current":-18.986811,"twenty":-19.432718,"median":-18.278327,"eighty":-17.567256,"marketCap":22989832281},{"date":"2021-06-04","current":-18.085054,"twenty":-19.394728,"median":-18.274791,"eighty":-17.569054,"marketCap":21794143605},{"date":"2021-06-11","current":-17.838307,"twenty":-19.380637,"median":-18.278327,"eighty":-17.596682,"marketCap":21495221436},{"date":"2021-06-18","current":-16.028857,"twenty":-19.316527,"median":-18.226089,"eighty":-17.499595,"marketCap":19158193568},{"date":"2021-06-25","current":-17.449469,"twenty":-19.090843,"median":-18.120466,"eighty":-17.407752,"marketCap":20843027612},{"date":"2021-07-02","current":-17.434433,"twenty":-19.054867,"median":-18.089655,"eighty":-17.397323,"marketCap":20788678127},{"date":"2021-07-09","current":-16.265645,"twenty":-19.040057,"median":-18.074879,"eighty":-17.195892,"marketCap":19375591509},{"date":"2021-07-16","current":-15.969405,"twenty":-19.032975,"median":-18.040488,"eighty":-17.122755,"marketCap":19022319855},{"date":"2021-07-23","current":-15.856864,"twenty":-19.023636,"median":-18.026565,"eighty":-17.079749,"marketCap":18886446141},{"date":"2021-07-30","current":-14.666803,"twenty":-18.986811,"median":-17.998882,"eighty":-16.849549,"marketCap":17527709009},{"date":"2021-08-06","current":-14.588335,"twenty":-18.965589,"median":-17.945733,"eighty":-16.750714,"marketCap":17391835296},{"date":"2021-08-13","current":-14.52296,"twenty":-18.953047,"median":-17.911145,"eighty":-16.470265,"marketCap":17337485810},{"date":"2021-08-20","current":-13.520478,"twenty":-18.945494,"median":-17.88088,"eighty":-16.251298,"marketCap":15217855884},{"date":"2021-08-27","current":-12.980395,"twenty":-18.88847,"median":-17.842996,"eighty":-16.122732,"marketCap":14674361031},{"date":"2021-09-03","current":-12.734842,"twenty":-18.882406,"median":-17.809029,"eighty":-15.859736,"marketCap":14402613604},{"date":"2021-09-10","current":-13.373232,"twenty":-18.846812,"median":-17.803134,"eighty":-15.761703,"marketCap":15163506398},{"date":"2021-09-17","current":-12.138916,"twenty":-18.846135,"median":-17.730953,"eighty":-15.089723,"marketCap":13723245038},{"date":"2021-09-24","current":-11.82096,"twenty":-18.810911,"median":-17.571343,"eighty":-14.867281,"marketCap":13369973383},{"date":"2021-09-30","current":-11.757587,"twenty":-18.785539,"median":-17.567074,"eighty":-14.603567,"marketCap":13342798641},{"date":"2021-10-08","current":-10.872073,"twenty":-18.769634,"median":-17.476946,"eighty":-14.333569,"marketCap":12337333163},{"date":"2021-10-15","current":-12.085096,"twenty":-18.725638,"median":-17.441951,"eighty":-13.86094,"marketCap":13723245038},{"date":"2021-10-22","current":-11.832626,"twenty":-18.639753,"median":-17.36388,"eighty":-13.648942,"marketCap":13533021839},{"date":"2021-10-29","current":-12.004873,"twenty":-18.601961,"median":-17.24697,"eighty":-13.384811,"marketCap":13696070295},{"date":"2021-11-05","current":-11.842443,"twenty":-18.587887,"median":-17.177529,"eighty":-13.069878,"marketCap":13533021839},{"date":"2021-11-12","current":-13.238443,"twenty":-18.539285,"median":-17.121354,"eighty":-12.950721,"marketCap":15190681141},{"date":"2021-11-19","current":-13.755236,"twenty":-18.493787,"median":-17.09849,"eighty":-12.989283,"marketCap":15761350737},{"date":"2021-11-26","current":-15.860878,"twenty":-18.471737,"median":-16.981974,"eighty":-13.021471,"marketCap":18179902832},{"date":"2021-12-03","current":-12.565895,"twenty":-18.441097,"median":-16.849549,"eighty":-12.989283,"marketCap":14429788347},{"date":"2021-12-10","current":-13.678439,"twenty":-18.435344,"median":-16.791123,"eighty":-12.950721,"marketCap":15734175994},{"date":"2021-12-17","current":-13.900665,"twenty":-18.427924,"median":-16.72442,"eighty":-12.950721,"marketCap":15978748678},{"date":"2021-12-24","current":-12.068814,"twenty":-18.41961,"median":-16.57278,"eighty":-12.854432,"marketCap":13886293494},{"date":"2021-12-31","current":-10.392945,"twenty":-18.411685,"median":-16.313069,"eighty":-12.599684,"marketCap":11984061508},{"date":"2022-01-07","current":-10.408899,"twenty":-11.114507,"median":-10.603378,"eighty":-10.458171,"marketCap":11956886766},{"date":"2022-01-14","current":-10.645935,"twenty":-11.136014,"median":-10.825867,"eighty":-10.516719,"marketCap":12255808935},{"date":"2022-01-21","current":-11.846284,"twenty":-11.23402,"median":-10.950741,"eighty":-10.575568,"marketCap":13668895552},{"date":"2022-01-28","current":-10.719633,"twenty":-11.23402,"median":-10.92037,"eighty":-10.575568,"marketCap":12337333163},{"date":"2022-02-04","current":-10.961121,"twenty":-11.226983,"median":-10.955931,"eighty":-10.603378,"marketCap":12609080589},{"date":"2022-02-11","current":-11.151206,"twenty":-11.195149,"median":-10.961121,"eighty":-10.645935,"marketCap":12853653273},{"date":"2022-02-18","current":-10.838643,"twenty":-11.151206,"median":-10.933229,"eighty":-10.645935,"marketCap":12554731104},{"date":"2022-02-25","current":-10.531157,"twenty":-11.149804,"median":-10.879658,"eighty":-10.555938,"marketCap":12228634192},{"date":"2022-03-04","current":-10.223007,"twenty":-11.133246,"median":-10.844907,"eighty":-10.526339,"marketCap":11875362538},{"date":"2022-03-11","current":-8.809298,"twenty":-11.096591,"median":-10.772075,"eighty":-10.439214,"marketCap":10217703236},{"date":"2022-03-18","current":-8.973146,"twenty":-11.067899,"median":-10.693082,"eighty":-10.247041,"marketCap":10859027162},{"date":"2022-03-25","current":-9.408384,"twenty":-11.060746,"median":-10.645935,"eighty":-9.613254,"marketCap":11386217170},{"date":"2022-04-01","current":-8.944167,"twenty":-11.060302,"median":-10.579658,"eighty":-9.555081,"marketCap":10837287368},{"date":"2022-04-08","current":-9.101703,"twenty":-11.051173,"median":-10.532504,"eighty":-9.487781,"marketCap":11032945515},{"date":"2022-04-14","current":-8.829357,"twenty":-10.996229,"median":-10.520302,"eighty":-9.272441,"marketCap":10685108809},{"date":"2022-04-22","current":-8.439191,"twenty":-10.958109,"median":-10.475675,"eighty":-9.02764,"marketCap":10022045089},{"date":"2022-04-29","current":-9.033079,"twenty":-10.95245,"median":-10.408899,"eighty":-8.917879,"marketCap":10554670045},{"date":"2022-05-06","current":-7.41082,"twenty":-10.943736,"median":-10.392945,"eighty":-8.839536,"marketCap":8587218677},{"date":"2022-05-13","current":-7.364351,"twenty":-10.915716,"median":-10.223007,"eighty":-8.8007,"marketCap":8380690633},{"date":"2022-05-20","current":-7.968917,"twenty":-10.889999,"median":-9.98237,"eighty":-8.584099,"marketCap":9195932912},{"date":"2022-05-27","current":-7.542162,"twenty":-10.879658,"median":-9.877618,"eighty":-8.1017,"marketCap":8695917648},{"date":"2022-06-02","current":-7.839485,"twenty":-10.877545,"median":-9.647965,"eighty":-8.02985,"marketCap":9087233942},{"date":"2022-06-10","current":-8.770543,"twenty":-10.856339,"median":-9.531356,"eighty":-7.992051,"marketCap":10098134368},{"date":"2022-06-17","current":-8.742365,"twenty":-10.841148,"median":-9.348726,"eighty":-8.004315,"marketCap":10054654780},{"date":"2022-06-24","current":-8.23701,"twenty":-10.797885,"median":-9.166898,"eighty":-8.03147,"marketCap":9511159927},{"date":"2022-06-30","current":-8.326656,"twenty":-10.778323,"median":-9.060482,"eighty":-8.076162,"marketCap":9598119103},{"date":"2022-07-08","current":-8.497078,"twenty":-10.769546,"median":-8.973146,"eighty":-8.128672,"marketCap":9804647148},{"date":"2022-07-15","current":-8.681154,"twenty":-10.738924,"median":-8.890871,"eighty":-8.173221,"marketCap":9924216015},{"date":"2022-07-22","current":-8.295377,"twenty":-10.687772,"median":-8.843947,"eighty":-8.192495,"marketCap":9489420133},{"date":"2022-07-29","current":-7.886667,"twenty":-10.657029,"median":-8.819327,"eighty":-8.057303,"marketCap":9032884456},{"date":"2022-08-05","current":-7.136107,"twenty":-10.647839,"median":-8.783241,"eighty":-7.981108,"marketCap":8152422795},{"date":"2022-08-12","current":-7.088387,"twenty":-10.632543,"median":-8.711759,"eighty":-7.937979,"marketCap":8108943206},{"date":"2022-08-19","current":-8.891947,"twenty":-10.611473,"median":-8.651267,"eighty":-7.857437,"marketCap":8619828368},{"date":"2022-08-26","current":-9.878492,"twenty":-10.574914,"median":-8.756454,"eighty":-7.879762,"marketCap":9500290030},{"date":"2022-09-02","current":-9.641847,"twenty":-10.542686,"median":-8.8007,"eighty":-7.911799,"marketCap":9239412501},{"date":"2022-09-09","current":-8.585571,"twenty":-10.532235,"median":-8.776892,"eighty":-7.937979,"marketCap":8195902383},{"date":"2022-09-16","current":-8.205928,"twenty":-10.52923,"median":-8.711759,"eighty":-7.947262,"marketCap":7761106500},{"date":"2022-09-23","current":-7.850954,"twenty":-10.521509,"median":-8.645731,"eighty":-7.931397,"marketCap":7282831030},{"date":"2022-09-30","current":-6.666434,"twenty":-10.504967,"median":-8.625033,"eighty":-7.852429,"marketCap":6195841324},{"date":"2022-10-07","current":-6.701906,"twenty":-10.484881,"median":-8.591202,"eighty":-7.761108,"marketCap":6228451015},{"date":"2022-10-14","current":-7.35301,"twenty":-10.456108,"median":-8.583249,"eighty":-7.57143,"marketCap":6761075971},{"date":"2022-10-21","current":-7.951253,"twenty":-10.433151,"median":-8.545175,"eighty":-7.57143,"marketCap":7261091236},{"date":"2022-10-28","current":-6.796392,"twenty":-10.406061,"median":-8.508514,"eighty":-7.508003,"marketCap":6195841324},{"date":"2022-11-04","current":-6.754512,"twenty":-10.394357,"median":-8.473127,"eighty":-7.42644,"marketCap":6217581118},{"date":"2022-11-11","current":-6.097932,"twenty":-10.363764,"median":-8.469242,"eighty":-7.395321,"marketCap":5663216368},{"date":"2022-11-18","current":-6.753098,"twenty":-10.242234,"median":-8.45243,"eighty":-7.346759,"marketCap":6250190809},{"date":"2022-11-25","current":-6.736071,"twenty":-10.196623,"median":-8.439191,"eighty":-7.272097,"marketCap":6184971427},{"date":"2022-12-02","current":-7.773909,"twenty":-10.077914,"median":-8.37957,"eighty":-7.241589,"marketCap":7261091236},{"date":"2022-12-09","current":-8.002157,"twenty":-10.008085,"median":-8.295377,"eighty":-7.250791,"marketCap":7543708559},{"date":"2022-12-16","current":-7.535454,"twenty":-9.932205,"median":-8.278653,"eighty":-7.272097,"marketCap":7087172883},{"date":"2022-12-23","current":-7.51,"twenty":-9.898083,"median":-8.243002,"eighty":-7.316458,"marketCap":7065433089},{"date":"2022-12-30","current":-7.305703,"twenty":-9.88339,"median":-8.22445,"eighty":-7.296997,"marketCap":6956734118},{"date":"2023-01-06","current":-7.457393,"twenty":-9.877968,"median":-8.206319,"eighty":-7.311066,"marketCap":7174132059},{"date":"2023-01-13","current":-8.437239,"twenty":-9.858414,"median":-8.206709,"eighty":-7.320093,"marketCap":8271991662},{"date":"2023-01-20","current":-8.286606,"twenty":-9.834445,"median":-8.240006,"eighty":-7.327535,"marketCap":8054593721},{"date":"2023-01-27","current":-8.57561,"twenty":-9.827001,"median":-8.248307,"eighty":-7.330074,"marketCap":8337211045},{"date":"2023-02-03","current":-8.175491,"twenty":-9.75546,"median":-8.23701,"eighty":-7.341519,"marketCap":7989374339},{"date":"2023-02-10","current":-7.777299,"twenty":-9.742113,"median":-8.206319,"eighty":-7.345196,"marketCap":7554578456},{"date":"2023-02-17","current":-8.009725,"twenty":-9.697444,"median":-8.193537,"eighty":-7.35301,"marketCap":7706757015},{"date":"2023-02-24","current":-8.177484,"twenty":-9.647965,"median":-8.202583,"eighty":-7.359122,"marketCap":7771976397},{"date":"2023-03-03","current":-8.136456,"twenty":-9.641847,"median":-8.205928,"eighty":-7.362303,"marketCap":7782846294},{"date":"2023-03-10","current":-7.532958,"twenty":-7.936227,"median":-7.807589,"eighty":-7.663468,"marketCap":7152392265},{"date":"2023-03-17","current":-6.893844,"twenty":-29.280721,"median":-16.418697,"eighty":-8.337386,"marketCap":6608897412},{"date":"2023-03-24","current":-6.658655,"twenty":-29.278482,"median":-16.330752,"eighty":-8.295377,"marketCap":6456718853},{"date":"2023-03-31","current":-6.382321,"twenty":-29.265473,"median":-16.265645,"eighty":-8.279201,"marketCap":6141491838},{"date":"2023-04-06","current":-6.996826,"twenty":-29.261938,"median":-16.251298,"eighty":-8.277923,"marketCap":6728466280},{"date":"2023-04-14","current":-9.166043,"twenty":-29.244948,"median":-16.177122,"eighty":-8.278324,"marketCap":7282831030},{"date":"2023-04-21","current":-10.375279,"twenty":-29.156297,"median":-16.110434,"eighty":-8.280198,"marketCap":8239381971},{"date":"2023-04-28","current":-9.791172,"twenty":-28.966769,"median":-16.017528,"eighty":-8.284669,"marketCap":7717626912},{"date":"2023-05-05","current":-9.403412,"twenty":-28.879119,"median":-15.969405,"eighty":-8.286606,"marketCap":7424139691},{"date":"2023-05-12","current":-9.274529,"twenty":-28.852641,"median":-15.860307,"eighty":-8.292601,"marketCap":7271961133},{"date":"2023-05-19","current":-8.816242,"twenty":-28.781694,"median":-15.853497,"eighty":-8.295377,"marketCap":6815425456},{"date":"2023-05-25","current":-7.906691,"twenty":-28.683645,"median":-15.812226,"eighty":-8.286122,"marketCap":6087142353},{"date":"2023-06-02","current":-7.650251,"twenty":-28.635789,"median":-15.707766,"eighty":-8.27382,"marketCap":5869744412},{"date":"2023-06-09","current":-7.718055,"twenty":-28.62839,"median":-15.523719,"eighty":-8.241804,"marketCap":5913224000},{"date":"2023-06-16","current":-8.211383,"twenty":-28.539889,"median":-15.189066,"eighty":-8.211383,"marketCap":6261060706},{"date":"2023-06-23","current":-7.66872,"twenty":-28.479972,"median":-15.018009,"eighty":-8.206397,"marketCap":5815394927},{"date":"2023-06-30","current":-8.028021,"twenty":-28.434831,"median":-14.894025,"eighty":-8.185553,"marketCap":6032792868},{"date":"2023-07-07","current":-9.203166,"twenty":-28.42021,"median":-14.728988,"eighty":-8.185553,"marketCap":6902384633},{"date":"2023-07-14","current":-9.275907,"twenty":-28.374356,"median":-14.588335,"eighty":-8.192495,"marketCap":7054563191},{"date":"2023-07-21","current":-9.07511,"twenty":-28.325294,"median":-14.52296,"eighty":-8.195817,"marketCap":6869774941},{"date":"2023-07-28","current":-9.214207,"twenty":-28.276566,"median":-14.467488,"eighty":-8.201914,"marketCap":6967604015},{"date":"2023-08-04","current":-8.538775,"twenty":-28.107178,"median":-14.183362,"eighty":-8.20624,"marketCap":6467588750},{"date":"2023-08-11","current":-8.096561,"twenty":-27.877746,"median":-13.991007,"eighty":-8.191975,"marketCap":6098012250},{"date":"2023-08-18","current":-7.762464,"twenty":-27.830986,"median":-13.842305,"eighty":-8.175132,"marketCap":5804525030},{"date":"2023-08-25","current":-26.697795,"twenty":-27.784384,"median":-13.828395,"eighty":-8.158004,"marketCap":5837134721},{"date":"2023-09-01","current":-29.706597,"twenty":-28.107178,"median":-13.888892,"eighty":-8.170209,"marketCap":6521938236},{"date":"2023-09-08","current":-30.060486,"twenty":-28.420665,"median":-14.123754,"eighty":-8.173421,"marketCap":6521938236},{"date":"2023-09-15","current":-29.580626,"twenty":-28.629171,"median":-14.286381,"eighty":-8.175132,"marketCap":6467588750},{"date":"2023-09-22","current":-28.661921,"twenty":-28.647461,"median":-14.50559,"eighty":-8.176288,"marketCap":6239320912},{"date":"2023-09-29","current":-25.921048,"twenty":-28.629171,"median":-14.562003,"eighty":-8.182864,"marketCap":5652346471},{"date":"2023-10-06","current":-24.561986,"twenty":-28.613095,"median":-14.613721,"eighty":-8.191454,"marketCap":5353424302},{"date":"2023-10-13","current":-26.92125,"twenty":-28.546356,"median":-14.838741,"eighty":-8.194677,"marketCap":5858874515},{"date":"2023-10-20","current":-24.986856,"twenty":-28.505231,"median":-14.94306,"eighty":-8.200576,"marketCap":5429513581},{"date":"2023-10-27","current":-30.077169,"twenty":-28.55348,"median":-15.089723,"eighty":-8.205928,"marketCap":6532808133},{"date":"2023-11-03","current":-36.685816,"twenty":-28.661921,"median":-15.342423,"eighty":-8.206709,"marketCap":7989374339},{"date":"2023-11-10","current":-34.996098,"twenty":-28.781694,"median":-15.589929,"eighty":-8.211383,"marketCap":7619797839},{"date":"2023-11-17","current":139.007258,"twenty":-28.852641,"median":-15.556824,"eighty":-8.205928,"marketCap":8271991662},{"date":"2023-11-24","current":134.06759,"twenty":-28.781694,"median":-15.273067,"eighty":-8.177484,"marketCap":8043723824},{"date":"2023-12-01","current":123.410206,"twenty":-28.717643,"median":-15.018009,"eighty":-8.168722,"marketCap":7435009589},{"date":"2023-12-08","current":115.396674,"twenty":-28.676471,"median":-14.894025,"eighty":-8.136456,"marketCap":6924124427},{"date":"2023-12-15","current":112.572734,"twenty":-28.665909,"median":-14.728988,"eighty":-8.09843,"marketCap":6793685662},{"date":"2023-12-22","current":105.438504,"twenty":-28.661921,"median":-14.588335,"eighty":-8.0768,"marketCap":6358889780},{"date":"2023-12-29","current":124.600197,"twenty":-28.660248,"median":-14.542482,"eighty":-8.068487,"marketCap":7554578456},{"date":"2024-01-05","current":123.318541,"twenty":-28.647461,"median":-14.50559,"eighty":-8.040462,"marketCap":7424139691},{"date":"2024-01-12","current":129.388505,"twenty":-28.629171,"median":-14.286381,"eighty":-8.023906,"marketCap":7793716192},{"date":"2024-01-19","current":128.482233,"twenty":-28.598191,"median":-14.123754,"eighty":-8.004007,"marketCap":7728496809},{"date":"2024-01-26","current":127.895751,"twenty":-28.539232,"median":-13.888892,"eighty":-7.991336,"marketCap":7663277427},{"date":"2024-02-02","current":117.16038,"twenty":-28.492602,"median":-13.828395,"eighty":-7.968917,"marketCap":7011083603},{"date":"2024-02-09","current":116.043963,"twenty":-28.441459,"median":-13.741036,"eighty":-7.955731,"marketCap":6978473912},{"date":"2024-02-16","current":117.464597,"twenty":-28.421577,"median":-13.690402,"eighty":-7.951253,"marketCap":7065433089},{"date":"2024-02-23","current":117.542093,"twenty":-28.419298,"median":-13.613328,"eighty":-7.941856,"marketCap":7032823397},{"date":"2024-03-01","current":119.647539,"twenty":-28.344394,"median":-13.512101,"eighty":-7.915092,"marketCap":7163262162},{"date":"2024-03-08","current":126.672019,"twenty":-28.296644,"median":-13.425131,"eighty":-7.869405,"marketCap":7587188147},{"date":"2024-03-15","current":136.411129,"twenty":-28.24645,"median":-13.3476,"eighty":-7.842873,"marketCap":8163292692},{"date":"2024-03-22","current":12.973937,"twenty":-28.044189,"median":-13.218965,"eighty":-7.777299,"marketCap":7695887118},{"date":"2024-03-28","current":12.519209,"twenty":-28.009087,"median":-13.100065,"eighty":-7.772172,"marketCap":7402399897},{"date":"2024-04-05","current":13.37366,"twenty":-27.959496,"median":-13.038286,"eighty":-7.76525,"marketCap":7902415162},{"date":"2024-04-12","current":13.568308,"twenty":-27.877746,"median":-12.982107,"eighty":-7.733431,"marketCap":8021984030},{"date":"2024-04-19","current":13.635105,"twenty":-27.845088,"median":-12.954555,"eighty":-7.711179,"marketCap":8054593721},{"date":"2024-04-26","current":15.199524,"twenty":-27.834055,"median":-12.900046,"eighty":-7.66971,"marketCap":8967665074},{"date":"2024-05-03","current":15.30222,"twenty":-27.818775,"median":-12.756941,"eighty":-7.639641,"marketCap":9022014559},{"date":"2024-05-10","current":15.81776,"twenty":-27.795706,"median":-12.554537,"eighty":-7.60133,"marketCap":9348111471},{"date":"2024-05-17","current":16.559383,"twenty":-27.750416,"median":-12.52579,"eighty":-7.583293,"marketCap":9772037456},{"date":"2024-05-24","current":17.391151,"twenty":-27.748227,"median":-12.491199,"eighty":-7.548422,"marketCap":10239443030},{"date":"2024-05-31","current":17.373469,"twenty":-27.745702,"median":-12.342599,"eighty":-7.532958,"marketCap":10239443030},{"date":"2024-06-07","current":17.395042,"twenty":-27.698671,"median":-12.324879,"eighty":-7.475268,"marketCap":10239443030},{"date":"2024-06-14","current":17.410995,"twenty":-27.635676,"median":-12.220722,"eighty":-7.447557,"marketCap":10239443030},{"date":"2024-06-21","current":17.44752,"twenty":-27.579411,"median":-12.146878,"eighty":-7.429881,"marketCap":10239443030},{"date":"2024-06-28","current":21.169921,"twenty":-27.531991,"median":-12.107468,"eighty":-7.409463,"marketCap":12418857391},{"date":"2024-07-05","current":21.31352,"twenty":-27.509142,"median":-12.073098,"eighty":-7.391342,"marketCap":12500381619},{"date":"2024-07-12","current":20.958398,"twenty":-27.436,"median":-12.028963,"eighty":-7.356677,"marketCap":12310158420},{"date":"2024-07-19","current":20.772946,"twenty":-27.320477,"median":-12.010321,"eighty":-7.327535,"marketCap":12201459449},{"date":"2024-07-26","current":20.696058,"twenty":-27.195166,"median":-11.942483,"eighty":-7.298439,"marketCap":12201459449},{"date":"2024-08-02","current":20.846486,"twenty":-27.093894,"median":-11.893713,"eighty":-7.252794,"marketCap":12282983677},{"date":"2024-08-09","current":20.754283,"twenty":-27.015113,"median":-11.837535,"eighty":-7.211803,"marketCap":12310158420},{"date":"2024-08-16","current":21.066803,"twenty":-26.967771,"median":-11.806904,"eighty":-7.168418,"marketCap":12500381619},{"date":"2024-08-23","current":20.886927,"twenty":-26.955307,"median":-11.609004,"eighty":-7.109109,"marketCap":12446032133},{"date":"2024-08-30","current":16.43423,"twenty":-26.948522,"median":-11.548619,"eighty":-6.995646,"marketCap":12500381619},{"date":"2024-09-06","current":16.533448,"twenty":-26.930541,"median":-11.45821,"eighty":-6.871599,"marketCap":12581905846},{"date":"2024-09-13","current":16.576841,"twenty":-26.803138,"median":-11.259414,"eighty":-6.79064,"marketCap":12581905846},{"date":"2024-09-20","current":16.406845,"twenty":-26.713756,"median":-11.226983,"eighty":-6.778362,"marketCap":12527556361},{"date":"2024-09-27","current":16.0965,"twenty":-26.474991,"median":-11.12377,"eighty":-6.734055,"marketCap":12364507905},{"date":"2024-10-04","current":16.063334,"twenty":-26.12212,"median":-11.064322,"eighty":-6.695364,"marketCap":12282983677},{"date":"2024-10-10","current":16.275333,"twenty":-25.921214,"median":-11.005246,"eighty":-6.664268,"marketCap":12364507905},{"date":"2024-10-18","current":16.144897,"twenty":-25.637712,"median":-10.902857,"eighty":-6.619301,"marketCap":12201459449},{"date":"2024-10-25","current":15.534605,"twenty":-25.112408,"median":-10.861622,"eighty":-6.595078,"marketCap":11739488824},{"date":"2024-11-01","current":15.739753,"twenty":-24.881781,"median":-10.769967,"eighty":-6.445564,"marketCap":11902537280},{"date":"2024-11-08","current":15.16169,"twenty":-24.562552,"median":-10.648314,"eighty":-6.336141,"marketCap":11413391913},{"date":"2024-11-15","current":14.703704,"twenty":-23.751057,"median":-10.532504,"eighty":12.609275,"marketCap":10951421287},{"date":"2024-11-22","current":14.783679,"twenty":-23.53783,"median":-10.449772,"eighty":13.062987,"marketCap":11005770773},{"date":"2024-11-29","current":15.706785,"twenty":-22.999838,"median":-10.31116,"eighty":13.490644,"marketCap":11685139339},{"date":"2024-12-06","current":16.219845,"twenty":-22.435947,"median":-10.035329,"eighty":13.731242,"marketCap":12038410993},{"date":"2024-12-13","current":16.288608,"twenty":-22.216491,"median":-9.890736,"eighty":14.555832,"marketCap":12065585736},{"date":"2024-12-20","current":17.613984,"twenty":-22.004449,"median":-9.806112,"eighty":14.82169,"marketCap":12989526986},{"date":"2024-12-27","current":17.627659,"twenty":-21.549335,"median":-9.748786,"eighty":14.920514,"marketCap":12989526986},{"date":"2025-01-03","current":17.426208,"twenty":-21.059501,"median":-9.644906,"eighty":15.101644,"marketCap":12853653273},{"date":"2025-01-10","current":17.15965,"twenty":-20.607327,"median":-9.566598,"eighty":15.217942,"marketCap":12609080589},{"date":"2025-01-17","current":14.05661,"twenty":-20.35213,"median":-9.486199,"eighty":15.260472,"marketCap":10337272104},{"date":"2025-01-24","current":11.824511,"twenty":-20.071108,"median":-9.37996,"eighty":15.260472,"marketCap":8750267133},{"date":"2025-01-28","current":12.245071,"twenty":-20.059273,"median":-9.37213,"eighty":15.246556,"marketCap":9108973736},{"date":"2025-02-07","current":14.732138,"twenty":-19.881739,"median":-9.29934,"eighty":15.274388,"marketCap":10897071802},{"date":"2025-02-14","current":15.503935,"twenty":-19.716064,"median":-9.259788,"eighty":15.394257,"marketCap":11440566655},{"date":"2025-02-21","current":15.602496,"twenty":-19.58997,"median":-9.203166,"eighty":15.430255,"marketCap":11576440368},{"date":"2025-02-28","current":20.173929,"twenty":-19.487135,"median":-9.138682,"eighty":15.600316,"marketCap":14918933714},{"date":"2025-03-07","current":22.691836,"twenty":-19.370014,"median":-9.081498,"eighty":15.678831,"marketCap":16848340443},{"date":"2025-03-14","current":22.646997,"twenty":-19.065782,"median":-8.992114,"eighty":15.77216,"marketCap":16821165700},{"date":"2025-03-21","current":22.326485,"twenty":-18.982567,"median":-8.937842,"eighty":15.869892,"marketCap":16576593016},{"date":"2025-03-28","current":21.446687,"twenty":-18.934089,"median":-8.881066,"eighty":15.958854,"marketCap":18832096656},{"date":"2025-04-03","current":20.496847,"twenty":-18.839523,"median":-8.833895,"eighty":16.064644,"marketCap":17962504891},{"date":"2025-04-11","current":17.855677,"twenty":-18.683014,"median":-8.776892,"eighty":16.101901,"marketCap":15543952795},{"date":"2025-04-17","current":21.145085,"twenty":-18.601961,"median":-8.681154,"eighty":16.211906,"marketCap":18451650259},{"date":"2025-04-25","current":23.553782,"twenty":-18.443201,"median":-8.6186,"eighty":16.246671,"marketCap":20571280186},{"date":"2025-05-02","current":25.056257,"twenty":-18.421123,"median":-8.595918,"eighty":16.285953,"marketCap":21930017318},{"date":"2025-05-09","current":21.736701,"twenty":-18.357986,"median":-8.578328,"eighty":16.307243,"marketCap":19158193568},{"date":"2025-05-16","current":24.221218,"twenty":-18.226089,"median":-8.538775,"eighty":16.352589,"marketCap":21522396178},{"date":"2025-05-23","current":25.67354,"twenty":-18.094256,"median":-8.474772,"eighty":16.43423,"marketCap":22881133311},{"date":"2025-05-30","current":28.32371,"twenty":-18.042007,"median":-8.459142,"eighty":16.529212,"marketCap":25354034892},{"date":"2025-06-06","current":27.615744,"twenty":-18.001357,"median":-8.448171,"eighty":16.543914,"marketCap":24783365296},{"date":"2025-06-13","current":28.93664,"twenty":-17.933569,"median":-8.429191,"eighty":16.59113,"marketCap":25979053973},{"date":"2025-06-20","current":29.114781,"twenty":-17.88088,"median":-8.326656,"eighty":16.663735,"marketCap":26087752944},{"date":"2025-06-27","current":30.394421,"twenty":-17.812992,"median":-8.289604,"eighty":17.360329,"marketCap":27310616363},{"date":"2025-07-04","current":33.810314,"twenty":-17.801509,"median":-8.277953,"eighty":17.373683,"marketCap":30381362282},{"date":"2025-07-11","current":31.664802,"twenty":-17.567437,"median":-8.248047,"eighty":17.392581,"marketCap":28424780811},{"date":"2025-07-18","current":38.172983,"twenty":-17.446462,"median":-8.211383,"eighty":17.398695,"marketCap":34240175739},{"date":"2025-07-25","current":37.581872,"twenty":-17.327692,"median":-8.192235,"eighty":17.415819,"marketCap":33832554599},{"date":"2025-08-01","current":40.093578,"twenty":-17.167788,"median":-8.170581,"eighty":17.4341,"marketCap":35870660298},{"date":"2025-08-08","current":44.992727,"twenty":-17.097162,"median":-8.121718,"eighty":17.480128,"marketCap":40354492835},{"date":"2025-08-15","current":50.734499,"twenty":-17.058582,"median":-8.093911,"eighty":17.621631,"marketCap":45436169710},{"date":"2025-08-22","current":50.833217,"twenty":-16.859598,"median":-8.068042,"eighty":18.705535,"marketCap":45381820225},{"date":"2025-08-29","current":46.979642,"twenty":-16.745455,"median":-8.037018,"eighty":20.138159,"marketCap":42338249048},{"date":"2025-09-05","current":49.410758,"twenty":-16.617085,"median":-8.00783,"eighty":20.53569,"marketCap":44485053718},{"date":"2025-09-12","current":47.905886,"twenty":-16.339663,"median":-7.991861,"eighty":20.742638,"marketCap":43207840813},{"date":"2025-09-19","current":46.794173,"twenty":-16.219396,"median":-7.96845,"eighty":20.789539,"marketCap":42175200592},{"date":"2025-09-26","current":43.258153,"twenty":-16.026591,"median":-7.951507,"eighty":20.858338,"marketCap":38887056732},{"date":"2025-10-03","current":44.331295,"twenty":-15.928376,"median":-7.944262,"eighty":20.881711,"marketCap":39946871695}],"updateTime":1759785296843},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02696\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2571176345","title":"BRIEF-Shanghai Henlius Biotech Says NMPA Approves Phase 1B/2 Trial For Hlx43 And Hlx07","url":"https://stock-news.laohu8.com/highlight/detail?id=2571176345","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571176345?lang=en_us&edition=fundamental","pubTime":"2025-09-30 18:17","pubTimestamp":1759227439,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Henlius Biotech Says NMPA Approves Phase 1B/2 Trial For Hlx43 And Hlx07Sept 30 (Reuters) - Shanghai Henlius Biotech Inc 2696.HK:NMPA APPROVES PHASE 1B/2 TRIAL FOR HLX43 AND HLX07Further company coverage: 2696.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VG0QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161"],"gpt_icon":0},{"id":"1191114042","title":"HENLIUS (02696): NMPA Approves Phase 1b/2 Clinical Trial Application for HLX43 Injection Combined with HLX07 in Advanced/Metastatic Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1191114042","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191114042?lang=en_us&edition=fundamental","pubTime":"2025-09-30 17:39","pubTimestamp":1759225191,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that the National Medical Products Administration (NMPA) has recently approved its Phase 1b/2 clinical trial application for HLX43 injection (PD-L1-targeted antibody-drug...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696"],"gpt_icon":0},{"id":"2571348601","title":"Shanghai Henlius Biotech Receives Regulatory Approval to Begin Phase 1b/2 Clinical Trial of HLX43 Combination Therapy for Advanced Solid Tumours in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2571348601","media":"Reuters","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571348601?lang=en_us&edition=fundamental","pubTime":"2025-09-30 17:31","pubTimestamp":1759224705,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech Receives Regulatory Approval to Begin Phase 1b/2 Clinical Trial of HLX43 Combination Therapy for Advanced Solid Tumours in China. **Shanghai Henlius Biotech Receives Regulatory Approval for New Cancer Clinical Trial** Shanghai Henlius Biotech Inc. announced that its application to conduct a Phase 1b/2 clinical trial of HLX43 for injection  in combination with HLX07  has been approved by China's National Medical Products Administration. The trial will focus on the treatment of advanced or metastatic solid tumours. Recent results from the phase 1 clinical trial, presented at the 2025 World Conference on Lung Cancer, showed promising efficacy and safety in patients with advanced solid tumours, particularly non-small cell lung cancer. The approval is specific to Shanghai Henlius Biotech Inc., with no indication of grant or funding involvement from other organizations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL2SyM5f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656","02696","BK1230","BK1161"],"gpt_icon":0},{"id":"2571348504","title":"Shanghai Henlius Biotech Inc - Nmpa Approves Phase 1B/2 Trial for Hlx43 and Hlx07","url":"https://stock-news.laohu8.com/highlight/detail?id=2571348504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571348504?lang=en_us&edition=fundamental","pubTime":"2025-09-30 17:30","pubTimestamp":1759224650,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VG0QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02696","BK1161"],"gpt_icon":0},{"id":"1191316700","title":"HENLIUS (02696): FDA Approves Phase 1 Clinical Trial Application for HLX13 as First-Line Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1191316700","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191316700?lang=en_us&edition=fundamental","pubTime":"2025-09-29 17:12","pubTimestamp":1759137132,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that the U.S. Food and Drug Administration (FDA) has recently approved the Investigational New Drug (IND) application for a Phase 1 clinical trial of the company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","HCC","BK1161","BK4006"],"gpt_icon":0},{"id":"2571383712","title":"Shanghai Henlius Biotech Receives FDA Approval for IND Application of HLX13 Ipilimumab Biosimilar for First-Line Treatment of Unresectable Hepatocellular Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2571383712","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571383712?lang=en_us&edition=fundamental","pubTime":"2025-09-29 17:04","pubTimestamp":1759136640,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech Receives FDA Approval for IND Application of HLX13 Ipilimumab Biosimilar for First-Line Treatment of Unresectable Hepatocellular Carcinoma. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL8f7TcZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","00656","BK1161","BK1230"],"gpt_icon":0},{"id":"2571383208","title":"Shanghai Henlius Biotech Inc - FDA Approves Ind for Hlx13 for Unresectable Hcc","url":"https://stock-news.laohu8.com/highlight/detail?id=2571383208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571383208?lang=en_us&edition=fundamental","pubTime":"2025-09-29 17:01","pubTimestamp":1759136501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nFWN3VE0IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02696"],"gpt_icon":0},{"id":"1197596150","title":"HENLIUS (02696) Completes First Patient Dosing in China for International Multi-Center Phase 1 Clinical Trial of Independently Developed Pembrolizumab Biosimilar HLX17 in Patients with Various Resected Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1197596150","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197596150?lang=en_us&edition=fundamental","pubTime":"2025-09-26 17:48","pubTimestamp":1758880131,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that the company has recently completed first patient dosing in China (excluding Hong Kong, Macau and Taiwan) for an international multi-center Phase 1 clinical trial of its...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696"],"gpt_icon":0},{"id":"2570100914","title":"Shanghai Henlius Biotech Doses First Patient in International Phase 1 Trial of Pembrolizumab Biosimilar HLX17 for Solid Tumours","url":"https://stock-news.laohu8.com/highlight/detail?id=2570100914","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570100914?lang=en_us&edition=fundamental","pubTime":"2025-09-26 17:42","pubTimestamp":1758879776,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech Doses First Patient in International Phase 1 Trial of Pembrolizumab Biosimilar HLX17 for Solid Tumours. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the original content used to generate this news brief on September 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDLbmlj9V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0198837287.USD","00656","BK1230","LU1791710400.SGD","BK4588","LU0648001328.SGD","02696","LU0477156797.USD","LU0528227936.USD","LU1201861165.SGD","BK4121","IQV","LU0648000940.SGD","BK4585","LU1791710582.SGD","LU1201861249.SGD","LU1261432733.SGD","LU1989764748.USD","LU0980610538.SGD","LU1989764664.SGD","LU0130518102.USD","LU0882574055.USD","BK4530","BK1161","LU0477156953.USD","LU0130517989.USD","LU0130102774.USD","LU0130103400.USD"],"gpt_icon":0},{"id":"2570803802","title":"What Recent Partnership News Means for Shanghai Henlius Biotech’s Valuation in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2570803802","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570803802?lang=en_us&edition=fundamental","pubTime":"2025-09-24 22:54","pubTimestamp":1758725649,"startTime":"0","endTime":"0","summary":"Deciding what to do with Shanghai Henlius Biotech stock these days? You are definitely not alone. The stock has been making waves and, depending on your lens, could be at an intriguing crossroads. If you are watching its recent movements, you might have caught last week’s dip of -11.8%. At first glance, that could spook even seasoned investors. But zoom out and you will notice a much bigger picture: despite the short-term stumble, Henlius has delivered an eye-popping 212.6% gain year to date...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/what-recent-partnership-news-means-for-shanghai-henlius-biot","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/what-recent-partnership-news-means-for-shanghai-henlius-biot","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02696","DCF","BK1161"],"gpt_icon":0},{"id":"2569733764","title":"Is Shanghai Henlius Biotech (SEHK:2696) Fairly Valued? A Fresh Look at Current Market Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2569733764","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569733764?lang=en_us&edition=fundamental","pubTime":"2025-09-22 20:11","pubTimestamp":1758543062,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (SEHK:2696) has been catching the attention of investors lately. There has not been a major event driving sudden headlines, but sometimes a period of relative calm can be just as telling, prompting new questions about what the market may be expecting from the company in the months ahead.\n\nThe stock’s journey over the last year has been anything but straightforward. While momentum has cooled in the past month, with a 7% dip, the share price is still up more than 2% for...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/is-shanghai-henlius-biotech-sehk2696-fairly-valued-a-fresh-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/is-shanghai-henlius-biotech-sehk2696-fairly-valued-a-fresh-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02696","BK1161"],"gpt_icon":0},{"id":"2568268151","title":"European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively","url":"https://stock-news.laohu8.com/highlight/detail?id=2568268151","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568268151?lang=en_us&edition=fundamental","pubTime":"2025-09-19 19:59","pubTimestamp":1758283140,"startTime":"0","endTime":"0","summary":"SHANGHAI and JERSEY CITY, N.J., Sept. 19, 2025 /PRNewswire/ -- ShanghaiHenlius Biotech, Inc. , and Organon  today announced the European Commission  has granted marketing authorization for BILDYOS  injection 60 mg/mL and BILPREVDA  injection 120 mg/1.7 mL,biosimilars to PROLIA  and XGEVA, respectively, for all indications of the reference products.[1],[2]. \"The EC approvals of BILDYOS and BILPREVDA mark a pivotal moment in expanding access to essential bone care treatments for millions of Europeans, particularly women, who are disproportionately affected by osteoporosis,\" said Nico Van Hoecke, Head, International Commercial at Organon.[3],[4] \"These biosimilars may offer additional treatment options across several therapeutic areas associated with bone loss, including osteoporosis, and reflect Organon's commitment to advancing women's health through access to important medicines.[4] These approvals, following those in the United States, not only expand the global reach of these biosimi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/european-commission-ec-approves-henlius-and-organons-bildyos-denosumab-and-bilprevda-denosumab-biosimilars-to-prolia-denosumab-and-xgeva-denosumab-respectively-302561484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","EC","BK4588","LU2065171311.SGD","BK4201","BK4007","EMA","LU2065169927.USD","02696","LU2065171402.SGD","BK4081","BK1161","BK4585","OGN","LU2065170008.USD"],"gpt_icon":0},{"id":"2568853252","title":"Organon, Shanghai Henlius Say EU Approves Denosumab Biosimilars","url":"https://stock-news.laohu8.com/highlight/detail?id=2568853252","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568853252?lang=en_us&edition=fundamental","pubTime":"2025-09-19 18:34","pubTimestamp":1758278072,"startTime":"0","endTime":"0","summary":"Organon  and partner Shanghai Henlius Biotech said Friday the European Commission granted marketing authorization for the Bildyos and Bilprevda injections, denosumab biosimilars to Prolia and Xgeva.The approvals cover all indications of the reference products, including treatment of osteoporosis and prevention of skeletal-related events in certain cancer patients, the companies said.Under a 2022 agreement, Organon holds exclusive rights to commercialize Bildyos and Bilprevda outside China.Prolia and Xgeva are trademarks registered in Europe by Amgen .","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1571399168.USD","SG9999001440.SGD","BK4588","LU1023059063.AUD","IE00B2B36J28.USD","BK4139","BK4156","BK4533","BK4581","BK4534","IE00BJT1NW94.SGD","IE0009355771.USD","AMGN","BK4007","LU0058720904.USD","IE00B4R5TH58.HKD","02696","IE00BFTCPJ56.SGD","LU0122379950.USD","LU0868494617.USD","LU1983299246.USD","LU0109394709.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4599","LU2112291526.USD","LU1061106388.HKD","BK4559","LU0889565916.HKD","LU2065169927.USD","BK4585","LU2065171402.SGD","LU0320765992.SGD","IE0002141913.USD","LU2065170008.USD","BK1161","BK4566","LU2242652126.USD","LU1057294990.SGD","OGN","LU2065171311.SGD","LU2468319806.SGD","LU2242646821.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"1119625906","title":"HENLIUS (02696): European Commission Approves HLX14 (Denosumab) Products for Osteoporosis Treatment in Specific Patient Populations","url":"https://stock-news.laohu8.com/highlight/detail?id=1119625906","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119625906?lang=en_us&edition=fundamental","pubTime":"2025-09-19 18:00","pubTimestamp":1758276025,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that the European Commission has recently approved the Marketing Authorization Applications (MAAs) for two products, BILDYOS® and BILPREVDA®. These brand names are...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161"],"gpt_icon":0},{"id":"2568752251","title":"European Commission (Ec) Approves Henlius and Organon’s Bildyos® (Denosumab) and Bilprevda® (Denosumab), Biosimilars to Prolia (Denosumab) and Xgeva (Denosumab), Respectively","url":"https://stock-news.laohu8.com/highlight/detail?id=2568752251","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568752251?lang=en_us&edition=fundamental","pubTime":"2025-09-19 18:00","pubTimestamp":1758276000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250919:nTUA3S3D66:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","OGN","BK4007","LU2065170008.USD","BK4588","02696","LU2065169927.USD","LU2065171402.SGD","LU2065171311.SGD","BK4585","BK1161"],"gpt_icon":0},{"id":"2568425113","title":"Shanghai Henlius Biotech Inc - Bilprevda® Approved for Skeletal Event Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2568425113","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568425113?lang=en_us&edition=fundamental","pubTime":"2025-09-19 17:51","pubTimestamp":1758275464,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250919:nFWN3V610I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02696","BK1161"],"gpt_icon":0},{"id":"2568251135","title":"Shanghai Henlius Biotech Inc - Ec Approves Hlx14 Products for Osteoporosis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2568251135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568251135?lang=en_us&edition=fundamental","pubTime":"2025-09-19 17:51","pubTimestamp":1758275464,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250919:nFWN3V610I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02696","BK1161"],"gpt_icon":0},{"id":"2568705944","title":"Henlius Biotech Doses First Patient in Lung Cancer Drug Trial in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2568705944","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568705944?lang=en_us&edition=fundamental","pubTime":"2025-09-18 21:00","pubTimestamp":1758200414,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech  dosed the first patient in a phase II clinical study of HLX43 for injection in Australia, a Thursday Hong Kong bourse filing said.The drug is being tested for the treatment of patients with advanced non-small cell lung cancer.The phase II study is also ongoing in mainland China and the US.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","02696","BK1161","XAO.AU","XKO.AU"],"gpt_icon":0},{"id":"1133990550","title":"HENLIUS (02696): First Patient Dosed in Australia for International Multi-center Phase 2 Clinical Study of HLX43 (PD-L1 Targeted Antibody-Drug Conjugate) for Advanced Non-Small Cell Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1133990550","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133990550?lang=en_us&edition=fundamental","pubTime":"2025-09-18 17:36","pubTimestamp":1758188192,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that an international multi-center Phase 2 clinical study of HLX43 (a PD-L1 targeted antibody-drug conjugate) in patients with advanced non-small cell lung cancer (NSCLC)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696","LU1169589451.USD","BK4023","LU1169590202.USD","PD"],"gpt_icon":0},{"id":"1196031664","title":"China Merchants Securities Maintains \"Strong Recommendation\" Rating on HENLIUS (02696), Optimistic About HLX43's Drug Development Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1196031664","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196031664?lang=en_us&edition=fundamental","pubTime":"2025-09-18 15:34","pubTimestamp":1758180869,"startTime":"0","endTime":"0","summary":"China Merchants Securities has issued a research report maintaining its \"Strong Recommendation\" rating on HENLIUS (02696). The company's latest HLX43 data update further validates its potential to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","06099","02696","BK1161","BK1147"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":102,"code":"91000000","status":"200"}]}}